Revenue for Q4 2023 was $93.25 billion, up 13.81% year-over-year and 2.06% quarter-over-quarter. Gross profit was $20.82 billion with a gross profit margin of 22.32%. Operating income stood at $7.69 billion, reflecting an operating margin of 8.25%. Net income for the quarter totaled $5.46 billion, translating to an EPS of $5.90. A notable increase in engagement levels was highlighted, with Optum Health serving 4 million patients in value-based care arrangements, growing by 900,000 in 2023 alone. Management also reported a charge of approximately $7 billion related to the sale of their Brazil operations, expected to impact future results but classified as non-cash.